New cardiology research presented at ...( #7710 IRREGULAR HEARTBEAT MAY DEVEL...)

#7710
IRREGULAR HEARTBEAT MAY DEVELOP AFTER LUNG TRANSPLANTATION
(Tuesday, October 28, 10:30 AM EST)

Patients receiving donated lungs may develop arrhythmias, including atrial fibrillation. Researchers from Baylor College of Medicine in Texas reviewed the charts of all lung transplant recipients in 2006 and 2007. Of the 75 patients who underwent lung transplant, 38 percent developed arrhythmias within 30 days of transplantation. The most common arrhythmia was atrial fibrillation, followed by atrial flutter. Researchers speculate that the donor-derived tissue (atrial cuff or pulmonary vein) is a likely source of the arrhythmias passed to lung recipients.

#6363
TADALAFIL PROVES EFFECTIVE THERAPY FOR PULMONARY HYPERTENSION
(Tuesday, October 28, 10:30 AM EST)

New research shows that the erectile dysfunction drug, tadalafil, may be an effective adjunct therapy for patients with pulmonary arterial hypertension (PAH). Italian researchers randomized 405 patients with PAH, of whom 53 percent were taking concomitant bosentan, to two study arms. The groups received either tadalafil or placebo orally once daily as monotherapy or as add-on therapy to bosentan. Compared with placebo, tadalafil, 40 mg, increased 6-minute walk distance, delayed the time to clinical worsening, and improved six of the eight short form (SF)-36 domains. In addition, tadalafil, 40 mg, increased cardiac output and reduced pulmonary artery pressures and pulmonary vascular resistance compared with baseline. Discontinuation due to adverse events was low (11 percent for tadalafil vs. 16 percent for placebo). Researchers conclude that tadalafil may provide an effective oral, once-daily therapy that can be combined with bosentan therapy for patients with PAH.

#6480
INSOMNIA DOES NOT PREDICT HIGH BLOOD PRESSURE
(Tuesday, October 28, 1:00 PM EST)

Difficulty falling asleep may be associated with a lower risk of hy
'/>"/>